NCT00135005View on ClinicalTrials.gov

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

AMN107, STI571

Trial Locations (5)

13125

Novartis Investigative Site, Berlin

20133

Novartis Investigative Site, Milan

69373

Novartis Investigative Site, Lyon

02115

Novartis Investigative Site, Boston

19111-2497

Novartis Investigative Site, Philadelphia

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY